Target intelligence / Profile preview

Hedyotis diffusa

Molecular classification
Botanical extract, Herbal medicine, Natural product source
01

Overview

Hedyotis diffusa, also known as Oldenlandia diffusa or Bai Hua She She Cao, is a well-known medicinal plant from the Rubiaceae family used extensively in Traditional Chinese Medicine (TCM). It is not a single molecular target or receptor but rather a botanical source containing a complex mixture of over 170 bioactive compounds, including iridoids, flavonoids, anthraquinones, and triterpenes such as ursolic acid and oleanolic acid [2][5]. Historically used for its heat-clearing and detoxifying properties, modern pharmacological research highlights its potent anti-tumor activities across various cancers, including colorectal, lung, liver, and breast cancers [1][6][13]. The therapeutic effects of Hedyotis diffusa are characterized by a multi-component, multi-target mechanism. Its active constituents modulate several critical signaling pathways, such as PI3K/Akt/mTOR, NF-κB, and STAT3, to inhibit cancer cell proliferation and induce apoptosis [1][5][10]. Additionally, it has been shown to suppress tumor angiogenesis by regulating factors like VEGFA and to enhance the body's non-specific immune response [1][10][11]. While widely used in clinical TCM practice, often in combination with Scutellaria barbata, it does not represent a discrete therapeutic protein target but serves as a natural product reservoir for diverse bioactive molecules [3][9].

Other names
White Hedyotis diffusaOldenlandia diffusaBai Hua She She CaoSnake-needle grassScleromitrion diffusumWhite flower spreading-tongue grass
02

Mechanism of action

Multi-target modulation involving the inhibition of PI3K/Akt/mTOR, NF-κB, and STAT3 signaling pathways; induction of the mitochondrial apoptotic pathway via Bax/Bcl-2 regulation; and suppression of angiogenesis through VEGFA inhibition.

03

Biological functions

Apoptosis inductionAnti-inflammatory activityImmunomodulationAnti-angiogenic activityAntioxidant activityCell cycle arrest
04

Disease associations

CancerInflammationHepatitisInfectionColorectal cancerLung adenocarcinomaProstate cancerCervical cancer
05

Safety considerations

Potential herb-drug interactionsLack of standardized dosage for whole-plant extractsLimited long-term safety data in human clinical trials for isolated extracts
06

Interacting drugs

Scutellaria barbata (commonly paired in TCM)

Beyond the preview

Go deeper on Hedyotis diffusa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hedyotis diffusa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call